Glaxo's Lotronex Risk-Management Program Emphasizes Appropriate Use

Glaxo Wellcome is proposing an "appropriate use" campaign as the focus of its risk-management plan for Lotronex, the company told FDA's Gastrointestinal Drugs Advisory Committee June 27.